Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 861-866

  Tamura, Akira ^a   Fujioka, Toshio ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLIC ACID BLOOD LEVEL; GASTROINTESTINAL ABSORPTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLIC ACID; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMOCYSTEINE; HUMANS; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN B 12;

EID: 0036120413     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)03957-6     Document Type: Article

References (46)

1. Helicobacter pylori: Its role in disease
2. Relation of Helicobacter pylori infection, and coronary heart disease
3. Association of Helicobacter pylori, and Chlamydia pneumoniae infections with coronary heart disease, and cardiovascular risk factors
4. Helicobacter pylori infection: Relation with cardiovascular risk factors, ischaemic heart disease, and social class
5. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men
6. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?
7. Helicobacter pylori seropositivity in subjects with acute myocardial infarction
8. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography
9. Helicobacterpylori infection, and coronary heart disease in the North Glasgow MONICA population
10. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general eldely population
11. Association of virulent Helicobacter pylori strains with ishemic heart disease
12. Helicobacter pylori seropositive and coronary heart disease incidence
13. Relation of Helicobacter pylori infection to 13-year mortality, and incident ischemic heart disease in the Carephilly Prospective Heart Disease Study
14. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: Lack of a role of cytotoxinassociated protein A-positive strains and absence of a systemic inflammatory response
15. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: Population based study of coronary heart disease
16. Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study
17. Helicobacter pylori serology in patients with angiographically documented coronary artery disease
18. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: Results from a large populationbased study
19. Prospective study of potentially viruluent strains of Helicobacter pylori and coronary heart disease in middle-aged men
20. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: Evidence from a population-based case-control study of myocardial infarction
21. Hyperhomocysteinnaemia, Helicobacter pylori, and coronary heart disease
22. Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status
23. Distribution of inflammation and artophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis
24. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis
25. Homocysteinemia: Vascular injury and arterial thrombosis
26. The pathogenesis of coronary artery disease: A possible role for methionine metabolism
27. Plasma homocyst(e)ine levels in men with premature coronary artery disease
28. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease
29. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
30. Homocysteine and coronary, atherosclerosis
31. Homocysteine and cardiovascular disease
32. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
33. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
34. Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine
35. Homocysteineinduced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
36. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
37. Oxidation of low density lipoprotein by thiol: Superoxide-dependent and -independent mechanisms
38. Helicobacter pylori infection and food-cobalamin malabsorption
39. Transfer of cobalamin from the cobalamin-binding protein of egg yolk to R binder of human saliva and gastric juice
40. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity
41. Ascorbic acid in the human stomach
42. Ascorbic acid: A factor concentrated in human gastric juice
43. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach
44. Nonenzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability
45. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
46. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase